Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per ...

Will two rare supernovas finally tell us how fast the universe is expanding? Perhaps, but we'll have to wait for it for them ...

Two ways of measuring how fast the universe is expanding disagree, a puzzle known as the Hubble tension. Tiny magnetic fields ...

Danaher Balances Solid 2025 Results With Cautious Outlook in Earnings Call Danaher Corporation’s latest earnings call struck a measured but positive tone, highlighting resilient cash generation, ...

Rainer M. Blair, President and Chief Executive Officer, stated, "We are encouraged by our third quarter results. DBS-driven execution paired with continued momentum in our bioprocessing business and ...

We are no longer able to provide Gainers and Losers data for constituents of S&P Australia and NZ indexes. We apologise for ...

Across the quiet darkness of space and the buried detectors under Antarctic ice, a set of stubborn anomalies is piling up.

Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to ...

The biochips market is projected to expand from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, driven by a CAGR of 8 ...

The main market opportunities in Syndromic Multiplex Diagnostics include the merging of Point of Care Testing and Molecular Diagnostics, which is streamlining frontline test protocols while reducing ...

Lipoprotein (a) is a low-density lipoprotein that transports cholesterol in the blood. The lipoprotein (a) test — or Lp(a) test — determines the level of this lipoprotein in the blood, and its results ...